Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by MNK3240on Jul 01, 2017 8:59am
198 Views
Post# 26426909

VRX: Class action against VRX (among others)

VRX: Class action against VRX (among others) Last couple of years, anytime VRX stock was doing well, a group of people start doing this. Not 100% sure but my guess is that next Option expiration date is Jul 21 and the big firms who have been shorting VRX stocks always look for some excuse to bring down the price to save (or profit) from the short positions before expiry. This will continute becz. every month there is an option expiry date,so the same game will go on either in the form of lawsuit or dumping stocks creating panic (and or an negative article in the big newspapers). Last few days, there was a sense that VRX is in bullish mode, so this is the best time to do something like this before it goes beyond control. 

Unfortunately, there are many big players in the market, so it won't be easy for Valeant to march forward!

======================================================================
Entwistle & Cappucci LLP ("Entwistle & Cappucci") and Susman Godfrey L.L.P. ("Susman Godfrey") today announced that they have filed a securities class action lawsuit on behalf of persons or entities that traded certain derivative securities of Allergan, Inc. (NYSE:AGN) ("Allergan" or the "Company") during the period February 25, 2014 through April 21, 2014, inclusive (the "Class Period"), and who thereby sustained damages (the "Class"). The case was filed in the United States District Court for the Central District of California, Case No. CV 17-04776-DOC (KESx), against Pershing Square Capital Management, L.P., Valeant Pharmaceuticals International, Inc. ("Valeant") and related defendants (collectively, "Defendants").
<< Previous
Bullboard Posts
Next >>